07
April
2020
|
09:16 AM
America/New_York

Sectra and Hospital for Special Surgery collaborate to integrate FDA approved digital pathology imaging solution

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has gone live with an initial phase of its digital pathology solution at New York’s Hospital for Special Surgery (HSS), the world’s leading academic medical center focused on musculoskeletal health. This module—incorporated within the existing Sectra enterprise imaging solution and integrated with laboratory information system Epic Beaker—provides integrated diagnostics capabilities between radiology and pathology, giving physicians a full patient overview of images across the two disciplines.

“The pathology team at HSS was thrilled to partner with Sectra on this initiative to integrate pathology and radiology diagnostics,” said Thomas Bauer, MD, PhD, Pathologist-in-Chief at HSS. “We believe this advancement will enhance the care we provide our surgical patients, which is what we strive for every day.”

Pathologists select slides of interest and scan them into the patient file. A microscope icon informs users that digital pathology images exist side-by-side with the radiology images. Physician users will then be able to navigate and zoom the whole slide images. HSS installed Sectra PACS for radiology in 2010 and added its specialty orthopedic modules in 2018.

“We are excited to see the benefits HSS will experience by incorporating digital pathology into their workflow. The ability for radiologists, pathologists, and surgeons to easily access both the radiology and pathology images should be a game-changer for patient care, especially in complex cancer cases,” says Mikael Anden, President of Sectra, Inc.

Sectra’s digital pathology solution received FDA clearance last week, read more here >>.

Epic and Beaker are registered trademarks of Epic Systems Corporation. 

About Sectra Imaging IT Solutions

With more than 30 years of innovation and approaching 2,000 installations worldwide, Sectra is a leading global provider of imaging IT solutions that support healthcare in achieving patient-centric care. Sectra offers an enterprise imaging solution comprising PACS for imaging-intense departments (radiology, pathology, cardiology, orthopedics), VNA, and share and collaborate solutions. Read more about Sectra and why Sectra PACS is “Best in KLAS” at https://medical.sectra.com/.

About HSS

HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the 14th consecutive year), No. 2 in rheumatology by U.S. News & World Report (2023-2024), and the best pediatric orthopedic hospital in NY, NJ and CT by U.S. News & World Report “Best Children’s Hospitals” list (2023-2024). In a survey of medical professionals in more than 20 countries by Newsweek, HSS is ranked world #1 in orthopedics for a fourth consecutive year (2023). Founded in 1863, the Hospital has the lowest readmission rates in the nation for orthopedics, and among the lowest infection and complication rates. HSS was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center five consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State, as well as in Florida. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. In addition, more than 200 HSS clinical investigators are working to improve patient outcomes through better ways to prevent, diagnose, and treat orthopedic, rheumatic and musculoskeletal diseases. The HSS Innovation Institute works to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is a trusted leader in advancing musculoskeletal knowledge and research for physicians, nurses, allied health professionals, academic trainees, and consumers in more than 165 countries. The institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally. www.hss.edu.